Joint Filing Agreement
Exhibit 99.1
The undersigned hereby agree that the Statement on Schedule 13G dated March 1, 2019 with respect to the Common Stock, $0.001 par value of Catalyst Biosciences, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: Xxxxx 0, 0000
XXXX HOLDINGS, INC. | |||
By: | /s/ Xxxxx Xxxx, Xx.
| ||
Name: | Xxxxx Xxxx, Xx. | ||
Title: | CEO, President and Executive Chairman | ||
JDS1, LLC | |||
By: |
/s/ Xxxxxx Xxxxxx | ||
Name: | Xxxxxx Xxxxxx | ||
Title: | Managing Member | ||
ACTINIUM CAPITAL, LP | |||
By: | Actinium Capital GP LLC, its general partner | ||
By: |
/s/ Xxxxxx Xxxxxx | ||
Name: | Xxxxxx Xxxxxx | ||
Title: | Managing Member | ||
ACTINIUM CAPITAL GP LLC | |||
By: |
/s/ Xxxxxx Xxxxxx | ||
Name: | Xxxxxx Xxxxxx | ||
Title: | Managing Member | ||
/s/ Xxxxx Xxxx, Xx. | |||
Xxxxx Xxxx, Xx. | |||
/s/ Xxxxx X. Xxxx | |||
Xxxxx X. Xxxx | |||
/s/ Xxxx Xxxx | |||
XXXX Xxxx | |||
/s/ Xxxxxx Xxxxxx | |||
Xxxxxx Xxxxxx |